Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catalyst Pharm Inc (NQ: CPRX )

3.490 USD -0.040 (-1.13%)
Official Closing Price Updated: 7:57 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Catalyst Pharm Inc

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update
From GlobeNewswire News Releases
InvestorNewsBreaks – A Glimpse into Robinhood’s 100 Most Popular Stocks
From InvestorBrandNetwork
Catalyst Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Catalyst Pharmaceuticals to Hold Third Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, November 10th, 2020
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Announces Filing of Patent Infringement Actions Against Jacobus Pharmaceuticals and PantherRx
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Announces Issuance of U.S. Patent for Firdapse®
Issued Patent is the First Covering Firdapse® 
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Announces Ruling on Lawsuit against the FDA and Intent to Appeal
From GlobeNewswire News Releases
KYE Pharmaceuticals and Catalyst Pharmaceuticals Challenge Health Canada’s Decision to Overlook Firdapse® Data Exclusivity
Notice of Application for Judicial Review Filed Today in the Federal Court of Canada 
From GlobeNewswire News Releases
Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce Agreement to Make Firdapse® (amifampridine phosphate) Available to LEMS Patients in Canada
From GlobeNewswire News Releases
Thinking about buying stock in AMAG Pharmaceuticals, Trevena Inc, Energous Corp, Catalyst Pharmaceuticals, or Plug Power?
InvestorsObserver issues critical PriceWatch Alerts for AMAG, TRVN, WATT, CPRX, and PLUG. 
From PR Newswire
Catalyst Pharmaceuticals Announces Notice of Allowance of a U.S. Patent Application for "Methods of Administering 3,4-Diaminopyridine"
-The allowed claims are directed to methods of treating patients with a 3,4-DAP sensitive disease comprising administering 3,4-DAP or a salt thereof to slow acetylating patients having certain... 
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Most Popular Robinhood Stocks: $CPRX $CRBP $NRZ
Tags The Market Signal
From The Market Signal
Catalyst Pharmaceuticals’ Firdapse® (amifampridine phosphate) Receives Marketing Approval in Canada for Patients with LEMS
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Announces Change to a Virtual Meeting Format for the 2020 Annual Meeting of Stockholders
From GlobeNewswire News Releases
Catalyst Pharmaceuticals to Hold Second Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 11th, 2020
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Comments on Magistrate Judge's Report and Recommendation in its Lawsuit against the FDA
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Appoints Jeffrey Del Carmen as Chief Commercial Officer
From GlobeNewswire News Releases
Catalyst Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Catalyst Pharmaceuticals to Hold First Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 12th, 2020
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Provides Update on Impact of COVID-19 Pandemic on its Business Activities
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 17th, 2020
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2020
From GlobeNewswire News Releases
Catalyst Pharmaceuticals to Present at the Cowen 40th Annual Health Care Conference
From GlobeNewswire News Releases
Catalyst Pharmaceuticals to Present at the 22nd Annual BIO CEO & Investor Conference
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Appoints David Ailinger as Vice President, Business Development
From GlobeNewswire News Releases
Catalyst Pharmaceuticals Pre-Announces Estimated Firdapse® Revenues and Provides Updates on Advancement of Clinical Development Programs
From GlobeNewswire News Releases
Catalyst Pharmaceuticals to Participate in the Piper Jaffray 31st Annual Healthcare Conference
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.